Why the TGA should reschedule MDMA and psilocybin for the treatment of mental illness
- Written by Sarah-Catherine Rodan, PhD candidate, University of Sydney
ShutterstockThe Therapeutic Goods Administration (TGA) is considering rescheduling psilocybin and MDMA from their current classification as Schedule 9 prohibited substances to Schedule 8 controlled substances.
This would allow psychiatrists to use these drugs in combination with psychotherapy for the treatment of conditions such as depression and...





